The Center for Pain Medicine offers a variety of interventions and therapies for the myriad of conditions that can cause pain. These range from simple outpatient procedures, such as trigger point injections and epidural steroid injections, to fluoroscopically guided procedures, such as facet joint injections, lumbar sympathetic blocks, spinal and peripheral stimulators, intrathecal medication delivery system, and nerve blocks.
The following are procedures performed at the Center for Pain Medicine at Brigham and Women’s Hospital.
Epidural steroid injection
Transforaminal epidural injections
Peripheral nerve injection
Trigger point injection
Celia plexus block
Spinal cord stimulator trials
Transverse abdominis plane (TAP) block
Epidural blood patch
Trigeminal nerve injection
Occipital nerve injection
Paravertebral facet injection
Brachial plexus injection
Pudendal nerve injection
Intercostal nerve injection
Celiac plexus block
Ganglion impar block
Cervical nerve injection
Each patient’s case presents a unique challenge, and occasionally multiple interventions or combinations may be appropriate. Through injections, pharmacologic management, physical therapy and other methods, we are equipped to treat nearly every condition that may cause pain.
Christopher J. Gilligan, MD, Chief, Division of Pain Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, discusses treatments available from the Center for Pain Medicine.
Patients who are unable to obtain satisfactory relief with the currently accepted regimens might be candidates for clinical trials that employ newer agents.
The Center’s philosophy is based on a unified approach to the evaluation and management of pain, focusing on comprehensive, interdisciplinary care of the whole patient, with consideration not only to physical functioning, but also to lifestyle and emotional health.
Dr. Gilligan’s vision for the Center includes providing the highest quality, safest and most compassionate care to every patient, conducting research that will lead to better and safer treatments, and training the next generation of leaders in our field.